Literature DB >> 28288028

The Obesity Paradox Is Not Observed in Critically Ill Patients on Early Enteral Nutrition.

Kimberley Harris1, Jiachen Zhou, Xinggang Liu, Erkan Hassan, Omar Badawi.   

Abstract

OBJECTIVES: To investigate the association between body mass index and mortality in a large, ICU population and determine if the relationship is observed among a subgroup of patients ordered early enteral nutrition.
DESIGN: Retrospective cohort study within a national clinical mixed ICU database of patients admitted between January 1, 2008, and June 30, 2015.
SETTING: Initial ICU admissions among patients monitored by tele-ICU programs and recorded in the Philips eICU Research Institute database. PATIENTS: A total of 1,042,710 adult patient stays with ICU length of stay more than 24 hours, of which 74,771 were ordered enteral nutrition within the first 48 hours. INTERVENTION: None.
MEASUREMENTS AND MAIN RESULTS: Patient stays from 409 ICUs were included. The average age, Acute Physiology and Chronic Health Evaluation IV score, and hospital mortality were 63.6 years, 56.7, and 9.0%, respectively. Hospital mortality among body mass index categories was estimated by multivariable modified Poisson regression models. Compared with the body mass index category 25.0-29.9 kg/m, hospital mortality was higher among underweight (body mass index, < 18.5; relative risk, 1.35; 95% CI, 1.32-1.39), normal weight (body mass index, 18.5-24.9; relative risk, 1.10; 95% CI, 1.09-1.12), and the extremely obese (body mass index, ≥ 50.0; relative risk, 1.10; 95% CI, 1.05-1.15). However, the risk was not statistically different from patients with body mass index 30.0-49.9 kg/m. Among patients ordered early enteral nutrition, the risk of mortality in the body mass index category 25.0-29.9 kg/m was not statistically different from those in the normal weight or extremely obese groups.
CONCLUSIONS: A survival advantage for overweight and obese patients was observed in this large cohort of critically ill patients. However, among those ordered early enteral nutrition, the survival disadvantage for body mass index categories less than 25.0 kg/m was minimal or unobservable when compared with higher body mass index categories.

Entities:  

Mesh:

Year:  2017        PMID: 28288028     DOI: 10.1097/CCM.0000000000002326

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Obesity Survival Paradox in the Critically Ill.

Authors:  Dominique J Pepper
Journal:  Crit Care Med       Date:  2017-08       Impact factor: 7.598

Review 2.  Obesity and the Survival of Critically Ill Patients with Acute Kidney Injury: A Paradox within the Paradox?

Authors:  Helmut Schiffl
Journal:  Kidney Dis (Basel)       Date:  2019-10-08

Review 3.  Mortality risk in patients with underweight or obesity with peripheral artery disease: a meta-analysis including 5,735,578 individuals.

Authors:  Donna Shu-Han Lin; Hao-Yun Lo; An-Li Yu; Jen-Kuang Lee; Kuo-Liong Chien
Journal:  Int J Obes (Lond)       Date:  2022-05-16       Impact factor: 5.551

4.  The impact of body mass index on the prognostic performance of the Simplified Acute Physiology Score 3: A prospective cohort study.

Authors:  Isabella B B Ferreira; Rodrigo C Menezes; Matheus L Otero; Thomas A Carmo; Gabriel A Agareno; Gabriel P Telles; Bruno V B Fahel; María B Arriaga; Kiyoshi F Fukutani; Licurgo Pamplona Neto; Sydney Agareno; Kevan M Akrami; Nivaldo M Filgueiras Filho; Bruno B Andrade
Journal:  Heliyon       Date:  2022-03-28

5.  Temporal Trends in Critical Care Outcomes in U.S. Minority-Serving Hospitals.

Authors:  John Danziger; Miguel Ángel Armengol de la Hoz; Wenyuan Li; Matthieu Komorowski; Rodrigo Octávio Deliberato; Barret N M Rush; Kenneth J Mukamal; Leo Celi; Omar Badawi
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

Review 6.  Sepsis Patients in Critical Care Units with Obesity: Is Obesity Protective?

Authors:  Charlene Kalani; Tejaswi Venigalla; Janay Bailey; George Udeani; Salim Surani
Journal:  Cureus       Date:  2020-02-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.